Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Dividends
Dividend Yield
Oramed Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Oramed Pharmaceuticals Inc
ORMP have decreased by 0%.
Payout Ratio
Oramed Pharmaceuticals Inc
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
ORMP is
.
Peers Comparison
Shareholder Yield
Price Appreciation
ORMP Price
Oramed Pharmaceuticals Inc
| Average Annual Return | -8.77% |
| Standard Deviation of Annual Returns | 43.71% |
| Max Drawdown | -94% |
| Market Capitalization | 153.3m USD |
| Shares Outstanding | 41 600 000 |
| Percentage of Shares Shorted | 4.21% |
ORMP Return Decomposition
Main factors of price return
Stock Splits
ORMP's latest stock split occurred on Jan 23, 2013
The company executed a 1-for-12 stock split, meaning that for every 12 shares held, investors received 1 new share.
Before the split, ORMP traded at 0.6 per share. Afterward, the share price was about 7.5.
The adjusted shares began trading on Jan 23, 2013. This was stock split number 2 in ORMP's history, following the previous one in Jun 14, 2004.